Does Medicare Cover CBD? Here’s What’s Actually Happening

You may have seen headlines suggesting that Medicare is starting to cover CBD.

And if your immediate reaction was:

Wait... WHAT?

You're not alone.

Something pretty significant is happening with hemp products and the federal healthcare system.

But no — Medicare did not suddenly decide everyone gets $500 worth of CBD gummies.

Here's what's actually going on.

First: This Isn't Traditional Medicare Coverage

In April 2026, the Centers for Medicare & Medicaid Services (CMS) introduced a new program called the Substance Access Beneficiary Engagement Incentive.

That's a mouthful, so here's the simple version:

Certain healthcare organizations participating in specific Medicare Innovation Center programs can now choose to provide eligible patients with up to $500 per year in qualifying hemp-derived products.

The program is optional, the healthcare organization has to participate and receive CMS approval, and the products must meet specific requirements.

Most importantly:

Medicare itself is not paying for or reimbursing these products.

Patients also can't walk into a CBD store, buy something and submit the receipt to Medicare.

So calling this simply “Medicare now covers CBD” isn't quite accurate.

So What Can Happen?

For participating organizations, qualifying hemp products can be incorporated into a patient's care plan under clinician guidance.

A qualified clinician must determine that using the product is appropriate for that individual, discuss potential risks and benefits, review medications and provide follow-up.

The healthcare organization — not the patient — is responsible for obtaining and providing the product.

And there are some pretty strict rules about what products qualify.

Not Every Hemp Product Makes the Cut

CMS requires eligible products to meet federal, state and local laws.

There are also restrictions involving THC content and product type.

Inhalable products don't qualify, for example.

Products must also meet quality and safety requirements, including third-party testing for cannabinoid potency and contaminants.

If you've been reading our blogs for a while, you probably know how we feel about that last part.

Test. Your. Products.

Why Is This Such a Big Deal?

This is the part we find fascinating.

For years, hemp-derived cannabinoid products have existed largely outside the traditional healthcare system.

Now we're seeing a federal healthcare agency establish an actual framework where certain legal hemp products can be discussed with patients, evaluated by clinicians and incorporated into care through participating organizations.

That doesn't mean the federal government has suddenly endorsed every CBD product or every claim surrounding cannabinoids.

CMS specifically says it is not making claims about the therapeutic value of these products.

But it does mean the conversation is changing.

And that's noteworthy.

There's Another Medicare Change Coming in 2027

CMS has also changed language surrounding certain supplemental benefits offered by Medicare Advantage plans beginning in 2027.

Previously, the rules broadly restricted cannabis products.

The updated language focuses instead on cannabis products that are illegal under applicable federal or state law.

That distinction matters because hemp and marijuana aren't treated identically under federal law.

Again, this doesn't mean every Medicare Advantage plan is about to start handing out CBD.

But it creates a more nuanced regulatory framework around legally compliant cannabis-derived products.

Can You Use Medicare to Buy CBD at Burning Acre?

Right now?

No.

You can't walk into Burning Acre, hand us your Medicare card and leave with federally covered CBD gummies.

And we'd rather tell you that than give you an exciting headline that isn't actually true.

But zoom out for a second.

We're now talking about:

Medicare programs.

Clinicians.

Third-party tested hemp products.

Cannabinoids.

All within the same federal healthcare framework.

For an industry that has spent decades fighting stigma and operating largely outside traditional healthcare, that's a pretty remarkable conversation to be having.

The Bottom Line

No, Medicare hasn't simply started covering CBD.

But CMS has created a pathway for certain participating healthcare organizations to provide qualifying hemp-derived products to eligible patients under clinician guidance, with up to $500 per year available through the program.

There are restrictions.

There are testing requirements.

There is clinical oversight.

And there are still plenty of questions about how programs like this will evolve.

But one thing is clear:

The relationship between hemp, cannabinoids and traditional healthcare is changing.

And we'll definitely be watching what happens next.

— The Burning Acre Team

This article is for general educational purposes only and does not constitute medical, insurance or legal advice. Eligibility and benefits depend on the specific CMS program, participating organization and applicable laws. Always verify your individual Medicare benefits directly with your healthcare provider or plan.